BRCA1/2-Mutated Breast Cancer In Select EU Markets- Incidence, Treatable Populations, And Potential Market Size For Parp Inhibitors
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.397
https://www.valueinhealthjournal.com/article/S1098-3015(17)30731-3/fulltext
Title :
BRCA1/2-Mutated Breast Cancer In Select EU Markets- Incidence, Treatable Populations, And Potential Market Size For Parp Inhibitors
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30731-3&doi=10.1016/j.jval.2017.08.397
First page :
A468
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
373